NDC 80425-0278-01 - Pantoprazole Sodium DR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0278
- Requested NDC
- 80425-0278-01
- Package NDCs from labels
- 80425-0278-2, 80425-0278-3, 80425-0278-1, 80425-0278-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pantoprazole Sodium DR - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0278-1 | Pantoprazole SodiumDR | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | 3 | |
| 80425-0278-2 | Pantoprazole SodiumDR | 60 in 1 BOTTLE | TABLET, DELAYED RELEASE | 60 | 3 | |
| 80425-0278-3 | Pantoprazole SodiumDR | 90 in 1 BOTTLE | TABLET, DELAYED RELEASE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0278 | PANTOPRAZOLE SODIUM DR (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 3 package rows | 20250102_f5c9e3c6-d4b0-0ebe-e053-2995a90abe55.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0278-1 | EA - Each | 80425-0278 | bae5f140-3078-4f84-8042-f2c7c68cb7a3 | 1 | 2023-06-06 |
| 80425-0278-2 | EA - Each | 80425-0278 | b70ad81b-245c-496c-89a5-8d751d2d07fe | 1 | 2023-04-07 |
| 80425-0278-3 | EA - Each | 80425-0278 | 0c89715f-22ca-495b-b639-8d879c5c70e5 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Aurobindo Pharma Limited | b3cec41e-e98b-470a-8ba2-c31537023989 | 2025-04-02 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release | PANTOPRAZOLE SODIUM GRANULES | Cipla USA Inc. | 195e06db-b76c-4470-b6a5-a3979c25046d | 2025-04-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | A-S Medication Solutions | 81696241-17d5-4d35-9e59-8c28469ffd2c | 2025-03-14 | Warnings, Adverse reactions | 314200 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Meitheal Pharmaceuticals Inc. | c18aff31-f91e-4b6a-9713-52c9094c6082 | 2025-03-13 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | BE Pharmaceuticals Inc. | 52d5bc28-66df-43aa-bb1a-8ac4a2a7f693 | 2025-03-07 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | 07ff83f9-7039-ac26-e063-6394a90a37ce | 2025-02-03 | Warnings, Adverse reactions | 314200 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NuCare Pharmaceuticals,Inc. | 8aac1642-6cb0-6ad2-e053-2a95a90a4cbd | 2025-01-31 | Warnings, Adverse reactions | 314200 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | NuCare Pharmaceuticals, Inc. | 2bed1bae-519f-1bb9-e063-6294a90a795b | 2025-01-29 | Warnings, Adverse reactions | 251872 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | d9fcf6a2-3788-4955-84d9-3c319b13267c | 2025-01-22 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | DIRECT RX | a7e7c1ab-3e75-1ff8-e053-2995a90a7539 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | ANDA202882 251872 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx of Tennessee, LLC | b3277cb8-26d0-bce0-e053-2a95a90af6dd | 2024-12-31 | Warnings, Adverse reactions | 251872 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | c89a5396-1d94-c7fa-e053-2995a90a9063 | 2024-12-31 | Warnings, Adverse reactions | ANDA202882 314200 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | bd4759ac-46b5-6903-e053-2a95a90a6319 | 2024-12-31 | Warnings, Adverse reactions | ANDA202882 314200 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | d27e1fdd-e23f-0d60-e053-2a95a90a9087 | 2024-12-31 | Warnings, Adverse reactions | 251872 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | f5c9e3c6-d4b0-0ebe-e053-2995a90abe55 | 2024-12-31 | Warnings, Adverse reactions | ANDA202882 80425-0278-1 80425-0278-3 80425-0278-2 80425-0278 80425027801 251872 2a9bf621-afb8-7627-e063-6294a90a77a9 f5c9e3c6-d4b0-0ebe-e053-2995a90abe55 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Fresenius Kabi USA, LLC | 340b57c2-bcf8-4f46-b522-886daaf80351 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Quality Care Products, LLC | a9fbf3b5-ddf4-4d3a-8b69-a0c38b3fa5e2 | 2024-12-19 | Warnings, Adverse reactions | 251872 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | a9f32edf-e0b9-4e96-e053-2a95a90afbc8 | 2024-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA202882 314200 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | American Health Packaging | 423dac8b-bb1e-4456-9b6e-913c028b11bc | 2024-10-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 6faf465b-c3a3-4ae7-9e16-1ba758f6962a | 2024-09-19 | Warnings, Adverse reactions | 314200 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.